Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OneMedNet (ONMD) Free Cash Flow (2022 - 2025)

OneMedNet has reported Free Cash Flow over the past 4 years, most recently at -$1.7 million for Q4 2025.

  • Quarterly Free Cash Flow rose 15.41% to -$1.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$7.5 million through Dec 2025, down 7.33% year-over-year, with the annual reading at -$7.5 million for FY2025, 7.33% down from the prior year.
  • Free Cash Flow was -$1.7 million for Q4 2025 at OneMedNet, down from -$1.6 million in the prior quarter.
  • Over five years, Free Cash Flow peaked at -$151653.0 in Q2 2022 and troughed at -$3.9 million in Q4 2022.
  • The 4-year median for Free Cash Flow is -$1.6 million (2024), against an average of -$1.5 million.
  • The largest YoY upside for Free Cash Flow was 55.54% in 2023 against a maximum downside of 535.66% in 2023.
  • A 4-year view of Free Cash Flow shows it stood at -$3.9 million in 2022, then surged by 55.54% to -$1.7 million in 2023, then dropped by 16.66% to -$2.0 million in 2024, then rose by 15.41% to -$1.7 million in 2025.
  • Per Business Quant, the three most recent readings for ONMD's Free Cash Flow are -$1.7 million (Q4 2025), -$1.6 million (Q3 2025), and -$2.3 million (Q2 2025).